These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 33923533
1. Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions. Fukuyama K, Nakano T, Shiroyama T, Okada M. Int J Mol Sci; 2021 Apr 16; 22(8):. PubMed ID: 33923533 [Abstract] [Full Text] [Related]
2. Effects of acute and sub-chronic administrations of guanfacine on catecholaminergic transmissions in the orbitofrontal cortex. Okada M, Fukuyama K, Kawano Y, Shiroyama T, Suzuki D, Ueda Y. Neuropharmacology; 2019 Sep 15; 156():107547. PubMed ID: 30802458 [Abstract] [Full Text] [Related]
3. Interaction between Mesocortical and Mesothalamic Catecholaminergic Transmissions Associated with NMDA Receptor in the Locus Coeruleus. Okada M, Fukuyama K. Biomolecules; 2020 Jul 01; 10(7):. PubMed ID: 32630356 [Abstract] [Full Text] [Related]
4. Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor. Fukuyama K, Kato R, Murata M, Shiroyama T, Okada M. Biomolecules; 2019 Jun 17; 9(6):. PubMed ID: 31213006 [Abstract] [Full Text] [Related]
11. Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. Franowicz JS, Kessler LE, Borja CM, Kobilka BK, Limbird LE, Arnsten AF. J Neurosci; 2002 Oct 01; 22(19):8771-7. PubMed ID: 12351753 [Abstract] [Full Text] [Related]
13. Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study. McCracken JT, McGough JJ, Loo SK, Levitt J, Del'Homme M, Cowen J, Sturm A, Whelan F, Hellemann G, Sugar C, Bilder RM. J Am Acad Child Adolesc Psychiatry; 2016 Aug 01; 55(8):657-666.e1. PubMed ID: 27453079 [Abstract] [Full Text] [Related]
14. Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd). Alamo C, López-Muñoz F, Sánchez-García J. Actas Esp Psiquiatr; 2016 May 01; 44(3):107-12. PubMed ID: 27254403 [Abstract] [Full Text] [Related]
15. Systemic administration of guanfacine improves food-motivated impulsive choice behavior primarily via direct stimulation of postsynaptic α2A-adrenergic receptors in rats. Nishitomi K, Yano K, Kobayashi M, Jino K, Kano T, Horiguchi N, Shinohara S, Hasegawa M. Behav Brain Res; 2018 Jun 01; 345():21-29. PubMed ID: 29476896 [Abstract] [Full Text] [Related]
16. Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder. Kawaura K, Karasawa J, Chaki S, Hikichi H. Behav Brain Res; 2014 Aug 15; 270():349-56. PubMed ID: 24882610 [Abstract] [Full Text] [Related]